Insulin resistance and neurodegeneration: progress towards the development of new therapeutics for Alzheimer's disease

SM De la Monte - Drugs, 2017‏ - Springer
Alzheimer's disease (AD) should be regarded as a degenerative metabolic disease caused
by brain insulin resistance and deficiency, and overlap** with the molecular, biochemical …

Brain metabolic dysfunction at the core of Alzheimer's disease

SM de la Monte, M Tong - Biochemical pharmacology, 2014‏ - Elsevier
Growing evidence supports the concept that Alzheimer's disease (AD) is fundamentally a
metabolic disease with molecular and biochemical features that correspond with diabetes …

Type 3 diabetes is sporadic Alzheimer׳ s disease: mini-review

SM de la Monte - European neuropsychopharmacology, 2014‏ - Elsevier
Alzheimer׳ s disease (AD) is the most common cause of dementia in North America.
Growing evidence supports the concept that AD is a metabolic disease mediated by …

Migraine triggers and oxidative stress: a narrative review and synthesis

JM Borkum - Headache: The Journal of Head and Face Pain, 2016‏ - Wiley Online Library
Background Blau theorized that migraine triggers are exposures that in higher amounts
would damage the brain. The recent discovery that the TRPA1 ion channel transduces …

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

S M. de la Monte - Current Alzheimer Research, 2012‏ - benthamdirect.com
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …

Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress

M Akbar, MM Essa, G Daradkeh, MA Abdelmegeed… - Brain research, 2016‏ - Elsevier
Mitochondria are important for providing cellular energy ATP through the oxidative
phosphorylation pathway. They are also critical in regulating many cellular functions …

Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?

S Cirmi, N Ferlazzo, GE Lombardo… - Molecules, 2016‏ - mdpi.com
Neurodegenerative diseases (ND) result from the gradual and progressive degeneration of
the structure and function of the central nervous system or the peripheral nervous system or …

Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin …

MB Khan, MM Khan, A Khan, ME Ahmed… - Neurochemistry …, 2012‏ - Elsevier
Oxidative stress is involved in Alzheimer's disease (AD)-type neurodegeneration with
cognitive impairment (AD-TNDCI) as well as age related cognitive deficit. The present study …

Malignant brain aging: the formidable link between dysregulated signaling through mechanistic target of rapamycin pathways and alzheimer's disease (type 3 …

SM de la Monte - Journal of Alzheimer's Disease, 2023‏ - journals.sagepub.com
Malignant brain aging corresponds to accelerated age-related declines in brain functions
eventually derailing the self-sustaining forces that govern independent vitality. Malignant …

Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease

M Tong, A Neusner, L Longato… - Journal of …, 2009‏ - content.iospress.com
The current epidemics of type 2 diabetes mellitus (T2DM), non-alcoholic steatohepatitis
(NASH), and Alzheimer's disease (AD) all represent insulin-resistance diseases. Previous …